Notably, a lower expression of genes implicated in DNA repair in CD34+ cells in peripheral blood stem cell products from patients pre-aHCT was associated with the later development of t-MDS/AML, an association that persisted in bone marrow cells at the time of diagnosis. This evidence concerns the gene CD34 and acute myeloid leukemia.